
Arindam Pal
With a strong background in Clinical development (study designing, PK (PK-PD) analysis, modelling & simulations, applied biostatistics) of... | Hyderabad, Telangana, India
*50 free lookup(s) per month.
No credit card required.
Arindam Pal’s Emails ar****@fe****.com
Arindam Pal’s Phone Numbers No phone number available.
Social Media
Arindam Pal’s Location Hyderabad, Telangana, India
Arindam Pal’s Expertise With a strong background in Clinical development (study designing, PK (PK-PD) analysis, modelling & simulations, applied biostatistics) of over 17 years, I work right from concepts’ ideation, validation, and leading them to regulatory submissions. I look after the in-vivo transitions from drug development which often involves PoC in preclinical models, ex-vivo models, in silico models, toxicology programs to full-fledged clinical phases (1-3). Clinical phase entailing First-in-man followed by clinical pharmacology (single and multiple ascending dose studies, food-effect, drug-drug PK interaction, PK-PD) and efficacy studies. My role also involves KoL engagements and external/internal collaborations. I have good hands-on experience in Phoenix NLME, Winnonlin & IVIVC toolkit. Basic experience in NONMEM. Fair experience in GastroPlus. Working with R and still learning. Well equipped with scientific and regulatory writing; have lots of experience in controlled correspondences and Scientific advice meetings. Worked in: Therapeutic areas: Urooncology, Gastroenterology, Reproductive medicine and maternal healthcare, Respiratory, Dermatology, Neurology and Pain management - Dosage forms: Solid and liquid orals (IR, MR), parenterals (with and without auto-injectors), inhalation (DPI, MDI), intranasal, topical, transdermal. - Clinical efficacy phases: 2-3 (superiority, non-inferiority, equivalence), organoleptic studies, device robustness studies. - Study types: RCT and observational studies (RWE) - Skill sets: study designing through statistical principles, data analysis & investigations, PK modelling and simulations and exposure-response analyses, IVIVC/R, preclinical-clinical translational analysis. Exposure in RWE and survival analysis.
Arindam Pal’s Current Industry Ferring Pharmaceuticals
Arindam
Pal’s Prior Industry
Cadila Healthcare
|
Zydus
|
Dr Reddys Laboratories
|
University Of Otago
|
Sandoz
|
Ferring Pharmaceuticals
Not the Arindam Pal you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Ferring Pharmaceuticals
Associate Director, Bioclinical studies
Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Sandoz
Clinical Development Manager, Sandoz
Sat Jun 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
University Of Otago
PhD student, Otago Pharmacometrics Group
Sat Dec 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed May 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Dr Reddys Laboratories
Principal Scientist
Mon Jan 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Nov 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Dr Reddys Laboratories
Senior Scientist level 2
Wed Jul 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Dec 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Dr Reddys Laboratories
Senior Scientist
Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jul 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Dr Reddys Laboratories
Scientist
Sat Jan 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Zydus
Assistant Research Scientist
Thu Jul 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Dec 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Cadila Healthcare
Research associate to Senior research associate
Sat Jul 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)